{"id":"W4402933950","doi":"10.3389/fonc.2024.1417484","title":"BRAF/MEK inhibitors use for pediatric gliomas; real world experience from a resource-limited country","year":2024,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; CDKN2A; Neurofibromatosis; Trametinib; MEK inhibitor; Dabrafenib; Oncology; Melanoma; Pleomorphic xanthoastrocytoma; Internal medicine; PDGFRA; Biopsy; Glioma; Gastroenterology; Cancer; Cancer research; MAPK/ERK pathway; Radiology; Astrocytoma; Vemurafenib; GiST; Kinase; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002658202,0.0004611005,0.0002469815,0.0003764675,0.0004360244,0.0004835687,0.0002372411,0.0002929997,0.001231057],"category_scores_gemma":[0.000877462,0.0001798173,0.0002345691,0.0006962303,0.0003989215,0.0004094258,0.000426834,0.0004350394,0.0003833771],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005274477,"about_ca_system_score_gemma":0.0007882527,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001135552,"about_ca_topic_score_gemma":0.002676546,"domain_scores_codex":[0.9997697,0.00006710183,0.00003307162,0.00003577645,0.00003561553,0.00005872692],"domain_scores_gemma":[0.9994025,0.00009424866,0.0002298162,0.00002778015,0.00005301786,0.0001925901],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009120721,0.001282296,0.6988788,0.0009694525,0.0001869203,0.1203553,0.00521483,0.001285434,0.007543039,0.0005175082,0.005436264,0.1574182],"study_design_scores_gemma":[0.0003480175,0.007338208,0.4968488,0.0004993108,0.0002735988,0.4293267,0.009550969,0.000950855,0.008373204,0.0003211277,0.04608084,0.00008834777],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937071,0.003648112,0.0003542901,0.0002283311,0.00001562592,0.00004897579,0.0001464257,0.00001482326,0.001836406],"genre_scores_gemma":[0.9907593,0.007163906,0.001028237,0.0003102511,0.0000619487,0.00003811754,0.0002484453,0.00001769378,0.0003721817],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001231057,"threshold_uncertainty_score":0.004118264,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02209467647078669,"score_gpt":0.309910914580263,"score_spread":0.2878162381094764,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}